Valvular heart disease cardiac catheterization: Difference between revisions
Jump to navigation
Jump to search
(/* 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary{{cite journal| author=Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA et al.| title=2014 AHA/ACC Guideline for the Management of ...) |
m (Bot: Removing from Primary care) |
||
| Line 35: | Line 35: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Valvular heart disease]] | [[Category:Valvular heart disease]] | ||
Latest revision as of 00:38, 30 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Valvular heart disease Microchapters |
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary[1]
| Class I |
| "1. Cardiac catheterization for hemodynamic assessment is recommended in symptomatic patients when noninvasive tests are inconclusive or when there is a discrepancy between the findings on noninvasive testing and physical examination regarding severity of the valve lesion. (Level of Evidence: C)" |
2006 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease - Indications for Cardiac Catheterization in Aortic Stenosis Patients (DO NOT EDIT) [2]
| Class I |
| "1. Coronary angiography is recommended before Aortic valve replacement in patients with aortic stenosis at risk for Coronary heart disease. (Level of Evidence: B) " |
| "2. Cardiac catheterization for hemodynamic measurements is recommended for assessment of severity of AS in symptomatic patients when noninvasive tests are inconclusive or when there is a discrepancy between noninvasive tests and clinical findings regarding severity of AS. (Level of Evidence: C)" |
| "3. Coronary angiography is recommended before AVR in patients with Aortic stenosis for whom a pulmonary autograft (Ross procedure) is contemplated and if the origin of the coronary arteries was not identified by noninvasive technique. (Level of Evidence: C)" |
| Class III (Harm) |
| "1. Cardiac catheterization for hemodynamic measurements is not recommended for the assessment of severity of AS before AVR when noninvasive tests are adequate and concordant with clinical findings. (Level of Evidence: C) " |
| "2. Cardiac catheterization for hemodynamic measurements is not recommended for the assessment of LV function and severity of AS in asymptomatic patients. (Level of Evidence: C) " |
References
- ↑ Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0000000000000029. PMID 24589852.
- ↑ Bonow RO, Carabello BA, Kanu C; et al. (2006). "ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons". Circulation. 114 (5): e84–231. doi:10.1161/CIRCULATIONAHA.106.176857. PMID 16880336. Unknown parameter
|month=ignored (help)